Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections.
Mustafa CakanNuray Aktay AyazGonca KeskindemirciŞerife Gül KaradağAyşe TanatarHafize Emine SönmezPublished in: Clinical rheumatology (2019)
Serum amyloid A is a sensitive but not specific marker for demonstrating inflammation in FMF. SAA levels rise substantially in febrile upper respiratory tract infections.Key Points• SAA levels rise substantially in febrile upper respiratory tract infections.• SAA is a sensitive but not specific method for demonstrating inflammation.• SAA cut-off value for discriminating FMF attacks from febrile infection is 111.5 mg/L (sensitivity 100%, specificity 65.1%).